We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $661B Turnover 17.31%
1-Year Est. Return 35.87%
 

UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.

This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+35.87%
3 Year Est. Return
+147.27%
5 Year Est. Return
+174.93%
10 Year Est. Return
+646.65%
AUM
$661B
AUM Growth
+$111B
Cap. Flow
+$105B
Cap. Flow %
15.88%
Top 10 Hldgs %
35.04%
Holding
4,339
New
650
Increased
2,860
Reduced
653
Closed
101
Avg Time Held
4.6 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
4.6 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.33B
2
MSFT icon
Microsoft
MSFT
+$5.9B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.47B
4
AAPL icon
Apple
AAPL
+$4.68B
5
AVGO icon
Broadcom
AVGO
+$4.5B

Sector Composition

Rank Sector Weight
1 Technology 40.99%
2 Financials 11.21%
3 Healthcare 9.46%
4 Consumer Discretionary 8.48%
5 Communication Services 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VRA icon
4126
Vera Bradley
VRA
$211M
$947 ﹤0.01%
205
– –
2026 Q1
2 quarters
ASUR icon
4127
Asure Software
ASUR
$322M
$946 ﹤0.01%
+125
New +$1.04K
2026 Q3
0 quarters
ANTX icon
4128
AN2 Therapeutics
ANTX
$175M
$942 ﹤0.01%
+177
New +$937
2026 Q3
0 quarters
GPCR icon
4129
Structure Therapeutics
GPCR
$1.34B
$938 ﹤0.01%
+30
New +$1.41K
2026 Q3
0 quarters
MYGN icon
4130
Myriad Genetics
MYGN
$535M
$935 ﹤0.01%
217
+179
+471% +$755
2013 Q2
53 quarters
RLTY icon
4131
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$245M
$914 ﹤0.01%
+66
New +$1.02K
2026 Q3
0 quarters
BOBS icon
4132
Bobs Discount Furniture
BOBS
$2.68B
$901 ﹤0.01%
+65
New +$1.06K
2026 Q3
0 quarters
AIRS icon
4133
AirSculpt Technologies
AIRS
$55.4M
$899 ﹤0.01%
+511
New +$1.74K
2026 Q3
0 quarters
ULBI icon
4134
Ultralife
ULBI
$262M
$898 ﹤0.01%
+139
New +$837
2026 Q3
0 quarters
RPT icon
4135
Rithm Property Trust
RPT
$85M
$878 ﹤0.01%
82
-145
-64% -$1.81K
2026 Q1
2 quarters
ALDX icon
4136
Aldeyra Therapeutics
ALDX
$39.5M
$871 ﹤0.01%
708
-4,117
-85% -$6.58K
2025 Q4
3 quarters
VEGN icon
4137
US Vegan Climate ETF
VEGN
$169M
$870 ﹤0.01%
+11
New +$851
2026 Q3
0 quarters
RUSC icon
4138
Russell Investments U.S. Small Cap Equity ETF
RUSC
$76.2M
$870 ﹤0.01%
24
– –
2026 Q1
2 quarters
PERI icon
4139
Perion Network
PERI
$363M
$869 ﹤0.01%
+100
New +$935
2026 Q3
0 quarters
AREC icon
4140
American Resources
AREC
$101M
$861 ﹤0.01%
+481
New +$1.03K
2026 Q3
0 quarters
ALT icon
4141
Altimmune
ALT
$311M
$852 ﹤0.01%
298
-3,856
-93% -$11.8K
2025 Q4
3 quarters
VHI icon
4142
Valhi
VHI
$482M
$817 ﹤0.01%
53
-262
-83% -$4.14K
2026 Q1
2 quarters
RBKB icon
4143
Rhinebeck Bancorp
RBKB
$204M
$799 ﹤0.01%
63
+18
+40% +$245
2025 Q4
3 quarters
RLMD icon
4144
Relmada Therapeutics
RLMD
$380M
$788 ﹤0.01%
+209
New +$1.02K
2026 Q3
0 quarters
ASLE icon
4145
AerSale
ASLE
$238M
$786 ﹤0.01%
150
– –
2026 Q1
2 quarters
UNB icon
4146
Union Bankshares
UNB
$113M
$782 ﹤0.01%
+34
New +$818
2026 Q3
0 quarters
MLAB icon
4147
Mesa Laboratories
MLAB
$766M
$780 ﹤0.01%
+6
New +$681
2026 Q3
0 quarters
OCGN icon
4148
Ocugen
OCGN
$257M
$778 ﹤0.01%
+755
New +$961
2026 Q3
0 quarters
MKC.V icon
4149
McCormick & Company Voting
MKC.V
$12.8B
$767 ﹤0.01%
+16
New +$841
2026 Q3
0 quarters
TLS icon
4150
Telos
TLS
$537M
$765 ﹤0.01%
188
-1,065
-85% -$4.8K
2025 Q4
3 quarters

Similar funds

UBS AM's Q3 2026 Portfolio in Review

As of Q3 2026, UBS AM held 4,339 positions worth $661B, up 20% from $550B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

UBS AM deployed $105B of net new capital in Q3 2026, opening 650 new positions and adding to 2,860 existing holdings. Its largest new stake was Dimensional US Vector Equity ETF: 720,289 shares worth $48.3M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 40% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $7.2B trimmed.

  • UBS AM's largest Q3 2026 buy was Dimensional US Vector Equity ETF: 720,289 shares worth $48.3M.
  • UBS AM added most to NVIDIA in Q3 2026, an estimated $6.33B increase.
  • UBS AM's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $7.2B.
  • UBS AM fully exited Electronic Arts in Q3 2026, selling an estimated $459M.
  • UBS AM's ten largest holdings make up 35% of its $661B portfolio in Q3 2026.
  • UBS AM opened 650 new positions and closed 101 in Q3 2026.
  • UBS AM's portfolio value rose 20% quarter-over-quarter to $661B.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.